Lumen‐apposing metal stents provide early and late clinical benefits for the management of benign gastrointestinal strictures: Is there a role for definitive therapy?
LAMS for benign gastrointestinal strictures are associated with high technical and early clinical success/LCS rates, positive quality-of-life metrics, and a tolerable adverse event rate. Overall, recurrence of symptoms and high reintervention rates post-LAMS removal reinforce the difficulty in managing benign gastrointestinal strictures but also argue for LAMS as a definitive therapy in select cases.
Authors
- Babusai Rapaka
- Rachel Mitchell (ORCID: https://orcid.org/0000-0003-1447-7515)
- Ali M. Ahmed (ORCID: https://orcid.org/0000-0002-8940-6757)
- Usman Barlass
- Ethan D. Pollack (ORCID: https://orcid.org/0000-0002-7607-9507)
- Kondal R. Kyanam Kabir Baig (ORCID: https://orcid.org/0000-0003-1550-4853)
- Dalton A. Norwood (ORCID: https://orcid.org/0000-0001-5408-560X)
- Shajan Peter (ORCID: https://orcid.org/0000-0003-3214-2989)
- Hector Caceres
- Ramzi Mulki (ORCID: https://orcid.org/0000-0001-5493-1407)
- Sergio A. Sánchez‐Luna (ORCID: https://orcid.org/0000-0001-6870-2226)
- Isaac Perry (ORCID: https://orcid.org/0000-0002-0989-2688)
- Jessica McCreight
Institutions
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- DEN Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/deo2.70005
- Citations
- 1
- Primary Topic
- Esophageal and GI Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.57